Sano Genetics | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision...


Sano Genetics LinkedIn profile Sano Genetics X profile Sano Genetics Facebook profile Sano Genetics Instagram profile
Sano Genetics logo

Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.

Website
Headquarters
Cambridge, England
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Genetics, Big Data, Research

🛍️ Sano Genetics Product and Pricing News →

👔 Sano Genetics CEO, Management and Leadership Team →

⚔️ Sano Genetics Alternatives and Competitors →

💼 Sano Genetics Hiring and Layoffs →

🤖 Sano Genetics Developer, Integration and Automation News →

📈 Sano Genetics Financials, Fundraising and Valuation News →

Monitor your competitors, clients, accounts, partners etc. with RivalSense AI


🛍️ Sano Genetics Product and Pricing News

  • Sano Genetics has been named in Bloomberg UK's Startups to Watch 2024 and announced a new partnership to enhance specialist eye care and research in the USA.
  • Sano Genetics has been named one of Bloomberg's Startups to Watch 2024, highlighting their innovation and diversity.
  • Sano Genetics is hosting the first-ever Genetics Podcast Meetup on November 7th in Denver.
  • Sano Genetics won silver in the Global Good Awards for their Genetics of Long Covid study and analysis with PrecisionLife, identifying 42 genes for potential drug discovery.
  • Paul Wicks, Vice President of Neuroscience at Sano Genetics, co-authored a new paper on DEI in digital mental health interventions with Woebot Health, published in the Journal of Medical Internet Research.

  • Sano Genetics' Paul Wicks co-authored a new paper in the Journal of Medical Internet Research on embedding DEI in digital mental health interventions.
  • Sano Genetics released a whitepaper on global market expansion and the future of precision medicine.
  • Sano Genetics highlights advancements in gene therapies and diagnostics for inherited retinal disorders, emphasizing the need for global collaboration and innovations like patient registries and AI-driven diagnostics.

👔 Sano Genetics CEO, Management and Leadership Team


⚔️ Sano Genetics Alternatives and Competitors

  • Akkure
  • |
  • Invitae
  • |
  • PreventionGenetics
  • |
  • Phase Genomics
  • |
  • Arima Genomics
  • |
  • 10x Genomics
  • |
  • Helix
  • |
  • Geneticure
  • |
  • Eugene
  • |
  • MedySapiens
  • |
  • Molecular You
  • |
  • SITraN
  • |
  • Cellartis
  • |
  • Fios Genomics
  • |
  • Glasgow Precision Oncology Laboratory
  • |
  • Renovacor
  • |
  • Eikon Therapeutics
  • |
  • Interius BioTherapeutics
  • |
  • Dermavant Sciences
  • |
  • Metrum Research Group
  • |
  • Clovis Oncology

Monitor your competitors, clients, accounts, partners etc. with RivalSense AI


💼 Sano Genetics Hiring and Layoffs

  • Paul Wicks, Vice President of Neuroscience at Sano Genetics, emphasized the importance of UK participants benefiting from promising drug research.
  • Amy Cousins, Senior Content Manager at Sano Genetics, is praised for her exceptional work and consultancy skills.


🤖 Sano Genetics Developer, Integration and Automation News

  • Sano Genetics is supporting a research program with Prevail Therapeutics to provide free at-home genetic testing and counseling for frontotemporal dementia (FTD).
  • Sano Genetics has launched a new partnership with 20/20 Onsite and Clinical Enrollment to improve participant selection for inherited retinal disease trials, announced during the American Academy of Ophthalmology event in Chicago.


📈 Sano Genetics Financials, Fundraising and Valuation News


People also viewed